HCG.NS(HCG.NS)
HCG.NS
No analyst ratings available
No analyst price targets available for HCG.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $29.20B | $33.49B | $38.88B |
| Low | $28.27B | $32.21B | $38.87B |
| High | $30.22B | $34.72B | $38.88B |
| EBITDA Avg | $6.50B | $7.46B | $8.66B |
| Low | $6.30B | $7.17B | $8.66B |
| High | $6.73B | $7.73B | $8.66B |
| EBIT Avg | $3.00B | $3.45B | $4.00B |
| Low | $2.91B | $3.31B | $4.00B |
| High | $3.11B | $3.57B | $4.00B |
| Net Income Avg | $1.27B | $2.12B | $3.48B |
| Low | $852M | $1.31B | $3.44B |
| High | $1.73B | $2.77B | $3.51B |
| EPS Avg | $9.43 | $15.45 | $24.25 |
| Low | $5.94 | $9.17 | $24.03 |
| High | $12.10 | $19.31 | $24.46 |
| Analysts (Rev / EPS) | 10 / 9 | 10 / 9 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.54B | $7.64B | $7.60B |
| Low | $7.54B | $7.64B | $7.60B |
| High | $7.54B | $7.64B | $7.60B |
| EBITDA Avg | $1.68B | $1.70B | $1.69B |
| Low | $1.68B | $1.70B | $1.69B |
| High | $1.68B | $1.70B | $1.69B |
| EBIT Avg | $775M | $786M | $782M |
| Low | $775M | $786M | $782M |
| High | $775M | $786M | $782M |
| Net Income Avg | $476M | $395M | $615M |
| Low | $476M | $395M | $615M |
| High | $476M | $395M | $615M |
| EPS Avg | $3.29 | $2.73 | $4.25 |
| Low | $3.29 | $2.73 | $4.25 |
| High | $3.29 | $2.73 | $4.25 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |